Sarepta Therapeutics, INC 13F institutional holdings
Quarterly disclosures of US equity positions held by institutional managers with over $100 million under management.
NASDAQ
Sarepta Therapeutics, Inc. has filed its quarterly 13F holdings report for the period ending March 31, 2026, detailing its investment positions.